Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah 10.98 MM.
- Nilai operating income untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah -159.21 MM.
- Nilai net income untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah -167.07 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 10.98 | -159.21 | -167.07 |
2025-03-31 | 7.99 | -152.55 | -161.18 |
2024-12-31 | 5.00 | -145.90 | -155.29 |
2024-09-30 | 2.50 | -512.02 | -537.75 |
2024-06-30 | -924.50 | -920.20 | |
2024-03-31 | -997.09 | -990.51 | |
2023-12-31 | -1,023.32 | -1,060.82 | |
2023-09-30 | -837.56 | -854.44 | |
2023-06-30 | -651.80 | -648.06 | |
2023-03-31 | -810.46 | -801.21 | |
2022-12-31 | -969.12 | -954.37 | |
2022-09-30 | 17.12 | -1,002.40 | -994.53 |
2022-06-30 | 34.23 | -1,035.68 | -1,034.70 |
2022-03-31 | 34.23 | -935.19 | -938.40 |
2021-12-31 | 34.23 | -834.70 | -842.10 |
2021-09-30 | 17.12 | -696.53 | -740.38 |
2021-06-30 | -558.36 | -638.67 | |
2021-03-31 | -479.05 | -573.49 | |
2020-12-31 | -399.74 | -508.30 | |
2020-09-30 | -348.23 | -418.91 | |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | -2.14 | -2.14 |
2024-03-31 | -2.31 | -2.31 |
2023-12-31 | -2.47 | |
2023-09-30 | -2.04 | -2.04 |
2023-06-30 | -1.59 | -1.59 |
2023-03-31 | -2.04 | -2.04 |
2022-12-31 | -2.53 | |
2022-09-30 | -2.68 | -2.68 |
2022-06-30 | -2.84 | -2.84 |
2022-03-31 | -2.60 | -2.60 |
2021-12-31 | -2.36 | |
2021-09-30 | -2.10 | -2.10 |
2021-06-30 | -1.84 | -1.84 |
2021-03-31 | -1.75 | -1.75 |
2020-12-31 | -1.64 | |
2020-09-30 | -1.47 | -1.47 |
2020-06-30 | -1.26 | -1.26 |
2020-03-31 | -1.12 | -1.12 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah -157.94 MM.
- Nilai cash from investing activities untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah 35.45 MM.
- Nilai kas dari aktivitas pendanaan untuk Kintor Pharmaceutical Limited per 2025 Jun 30 adalah -144.85 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -157.94 | 35.45 | -144.85 |
2025-03-31 | -178.51 | 27.74 | -132.26 |
2024-12-31 | -199.08 | 20.03 | -119.67 |
2024-09-30 | -241.76 | 11.20 | -102.33 |
2024-06-30 | -284.44 | 2.36 | -84.98 |
2024-03-31 | -336.01 | 2.81 | -59.22 |
2023-12-31 | -387.58 | 3.27 | -33.46 |
2023-09-30 | -427.27 | 14.35 | 376.17 |
2023-06-30 | -466.95 | 25.42 | 785.79 |
2023-03-31 | -714.11 | 46.31 | 800.77 |
2022-12-31 | -961.26 | 67.19 | 815.75 |
2022-09-30 | -1,144.48 | 222.50 | 448.78 |
2022-06-30 | -1,327.69 | 377.80 | 81.81 |
2022-03-31 | -1,189.53 | 234.90 | 469.61 |
2021-12-31 | -1,051.36 | 92.00 | 857.42 |
2021-09-30 | -850.90 | -279.24 | 843.56 |
2021-06-30 | -650.43 | -650.48 | 829.70 |
2021-03-31 | -515.66 | -545.10 | 1,305.00 |
2020-12-31 | -380.88 | -439.73 | 1,780.30 |
2020-09-30 | -340.75 | -243.58 | 1,930.92 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.21.
- roe untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.43.
- roic untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.36.
- croic untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.69.
- ocroic untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.47.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.21 | -0.43 | -0.36 | -0.69 | -0.47 |
2025-03-31 | -0.21 | -0.41 | -0.36 | -0.69 | -0.47 |
2024-12-31 | -1.06 | -0.34 | -1.46 | -0.59 | -0.45 |
2024-09-30 | -1.06 | -1.17 | -1.46 | -0.59 | -0.45 |
2024-06-30 | -0.57 | -0.75 | -1.45 | -0.57 | -0.53 |
2024-03-31 | -1.49 | -0.59 | -0.54 | ||
2023-12-31 | -0.32 | -0.43 | -0.52 | -0.02 | -0.26 |
2023-09-30 | -0.37 | -0.55 | -0.39 | 0.21 | -0.28 |
2023-06-30 | -0.55 | -0.55 | -0.39 | 0.21 | -0.28 |
2023-03-31 | -0.55 | -0.67 | -0.50 | 0.09 | -0.44 |
2022-12-31 | -0.50 | -0.60 | -0.58 | -0.28 | -0.66 |
2022-09-30 | -0.50 | -0.60 | -0.58 | -0.28 | -0.66 |
2022-06-30 | -0.35 | -0.48 | -0.76 | -0.66 | -0.98 |
2022-03-31 | -0.35 | -0.43 | -0.69 | -0.38 | -0.88 |
2021-12-31 | -0.34 | -0.56 | -0.47 | -0.08 | -0.28 |
2021-09-30 | -0.40 | -0.49 | -0.41 | -0.19 | -0.28 |
2021-06-30 | -0.29 | -0.35 | -0.27 | -0.24 | -0.27 |
2021-03-31 | -0.26 | -0.32 | -0.24 | 0.06 | -0.22 |
2020-12-31 | -0.92 | -1.38 | -0.29 | 0.50 | -0.22 |
2020-09-30 | -0.76 | -1.13 | -0.24 | 0.75 | -0.20 |
2020-06-30 | -0.78 | -1.31 | -0.16 | 0.86 | -0.15 |
2020-03-31 | -0.66 | -1.12 | -0.14 | 0.44 | -0.13 |
Gross Margins
- marjin kotor untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -0.95.
- marjin bersih untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -31.06.
- marjin operasi untuk Kintor Pharmaceutical Limited pada 2025 Jun 30 adalah -29.92.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | -0.95 | -31.06 | -29.92 |
2025-03-31 | -0.95 | -31.06 | -28.91 |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | 1.00 | -58.11 | -58.37 |
2022-09-30 | 1.00 | -58.11 | -58.37 |
2022-06-30 | 1.00 | -30.23 | -30.29 |
2022-03-31 | 1.00 | -27.41 | -27.34 |
2021-12-31 | -24.60 | -24.03 | |
2021-09-30 | -43.26 | -39.74 | |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |